PATIENTS taking blockbuster diabetes and weight loss drugs are waking up with vision loss, researchers warn. Some reported ...
While this condition can be caused by diabetes, tissue disease and neurological disorders, which damage the nerves and blood ...
Novo Nordisk and Eli Lilly, the companies behind Ozempic, Wegovy, and Mounjaro, have made a request to the Australian government.
Ozempic and other glucagon-like peptide-1 (GLP-1) agonists are a transformative new class of medicines for the treatment of diabetes and obesity, while also delivering other health benefits, such as ...
Use precise geolocation data. Actively scan device characteristics for identification. Store and/or access information on a ...
A new study suggests a possible link between GLP-1 weight loss drugs like Ozempic and Mounjaro and vision problems, including sudden vision loss. Researchers are investigating whether these ...
Medical experts have raised concerns over popular weight loss drugs like Ozempic and Mounjaro after emerging evidence found ...